Subscribe to our news feed
A question?
18.06.2026
Getinge launches Fluobeam LS, advancing fluorescence imaging for small-incision procedures
Getinge today announces the launch of Fluobeam LS, expanding its fluorescence imaging portfolio for small-incision surgery. Designed for procedures such as thyroid surgery and sentinel lymph node (SLN) detection in breast cancer, the device helps surgeons identify anatomical structures that are difficult to distinguish by providing real-time visualization to assist intraoperative decision-making.
11.06.2026
Getinge elevates automated endoscope reprocessing with Aquadis Endo 110
Today, Getinge announced the launch of Aquadis Endo 110, a next-generation automated endoscope reprocessor designed to increase processing capacity, simplify workflows and enhance safety for both patients and healthcare professionals. Building on decades of expertise in infection control and sterile reprocessing, Aquadis Endo 110 sets a new benchmark for fast, reliable cleaning and high-level disinfection of flexible endoscopes, helping reduce the risk of healthcare‑associated infections.
10.06.2026
Self-sufficient, mobile pediatric heart clinic performs groundbreaking surgeries in Burundi
Supported by several products from global medtech company Getinge, the German non-profit organization kinderherzen continues to save the lives of children in countries with no or inadequate access to cardiac care.
02.06.2026
Getinge Launches Vasoview Hemopro 3, Advancing Endoscopic Vessel Harvesting
Getinge today announced the launch of the Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) System, including the Hemopro 3 Harvesting Tool and dedicated Hemopro 3 Power Supply. Designed for clinicians, by clinicians, the system represents the latest evolution of Getinge’s EVH platform, enhancing decades of experience supporting coronary artery bypass grafting (CABG) procedures.
28.05.2026
Getinge’s subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.
Getinge today announces that a jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed Inc (“Abiomed”) in a patent dispute between Getinge’s subsidiary Maquet Cardiovascular LLC (“Maquet”) and Abiomed. The jury found that Abiomed has not infringed any Maquet patents relating to intravascular heart pump technology.
Press Contacts
Caroline Örmgård
Phone: +46 10 335 0041
Lars Mattsson
Phone: +46 10 335 0043
Contact us online
Click below to fill in the appropriate form. We will be in touch shortly.
Are you looking for
Image Gallery
Diverse picture format made available for press article purpose
About us
All you need to know about Getinge a one glance
Urgent Medical Device Correction
Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)
Don't miss anything
Click on the icons and follow us!